Maravai LifeSciences Stock (NASDAQ: MRVI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 2.760M |
Day Range | - - - |
52 Wk Range | 4.520 - 16.620 |
Market Cap | $1.021B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 4.64% |
Days to Cover | 1.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Maravai LifeSciences (NASDAQ: MRVI) through any online brokerage.
Other companies in Maravai LifeSciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).
The latest price target for Maravai LifeSciences (NASDAQ: MRVI) was reported by Craig-Hallum on Wednesday, April 10, 2024. The analyst firm set a price target for 15.00 expecting MRVI to rise to within 12 months (a possible 94.30% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Maravai LifeSciences (NASDAQ: MRVI) is $7.72 last updated April 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Maravai LifeSciences.
Maravai LifeSciences’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Maravai LifeSciences.
Maravai LifeSciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.